1. Home > Latest Topics >

Question 12: Who should be treated with high-dose levofloxacin?

20 June, 2018

question_12_4


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Changes and Updates in the New ATS/IDSA 2019 CAP Guidelines
06 May, 2021
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin
07 October, 2021
Urinary tract infection: Diagnosis and treatment strategies
23 August, 2021
Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023
Optimising the management of patients with community-acquired pneumonia and comorbidities with levofloxacin
05 December, 2022